Explore the Q4 2025 Alger Weatherbie Specialized Growth Fund performance. Read about the top contributors and detractors in ...

With sustained political will, private-sector discipline, and deliberate planning informed by the lessons of neighboring states, Kaima Smart City has the potential to redefine urban development in ...

Data represents up to 8.5 years of follow-up and are consistent across age, dose, and genotypeBLA resubmitted to U.S. FDA in January 2026; ...

By: Dr. Amrit Kaur Kaler For patients diagnosed with blood cancers such as leukemia, lymphoma, and multiple myeloma, the ...

Data represents up to 8.5 years of follow-up and are consistent across age, dose, and genotype BLA resubmitted to U.S. FDA in January 2026; Company expects up to six-month review period per FDA guidel ...

Acadia Pharmaceuticals (NasdaqGS:ACAD) received a negative trend vote from the European Medicines Agency's Committee for Medicinal Products for Human Use on its Rett syndrome treatment, trofinetide.

Leiden, the Netherlands Tuesday, February 3, 2026, 18:00 Hrs [IST] ...

Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary sarcoidosis is scheduled for mid-April 2026.

Summary The February 2026 merger of SpaceX and xAI marks a pivot from algorithmic optimization to physical infrastructure scaling at a planetary level. By vertically integrating heavy-lift launch ...

SpaceX has acquired xAI to create a $1 trillion entity pursuing orbital AI data centers, with plans to deploy up to one million satellites in space.

Kim Kardashian and Lewis Hamilton spark romance rumors, Yeni Kuti slams comparisons between Fela and today’s artists, South Africa set to replace Morocco as WAFCON hosts. Stay in the know with our ...

The DGIST Center for Synapse Diversity and Specificity has identified MDGA2 as a novel causative gene for developmental and epileptic encephalopathy (DEE), a rare and intractable neurological disorder ...